Stock Rich List
Nasdaq: KLRS

Kalaris Therapeutics insiders

The officers, directors and 10% owners of Kalaris Therapeutics, Inc. who hold the most stock, valued at the live KLRS price.

$1.35
KLRS today −$20K (−1.46%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
5
Their KLRS stock
$3.8M
Market value
$32.1M
Held by ranked insiders
11.7%

Insiders by value of KLRS holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Vikas SinhaSee Remarks955,365$1.3M4.01%3543rd
2Gilead Sciences, Inc.10% owner723,273$976K3.04%Corporate
3Morana Jovan-EmbiricosDirector612,912$827K2.57%3732nd
4David HallalDirector311,803$421K1.31%1576th
5Ansbert GadickeDirector182,560$246K0.77%13301st

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Kalaris Therapeutics; see each profile for the filing.